Filing Flows › Impact Biomedical (IBO) › How it makes money
How Impact Biomedical (IBO) makes money
Impact Biomedical (IBO) made $3K of revenue in the second quarter 2026 (Q2 2026), -57% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $3K | 100.0% |
| Operating cash flow | $470K | n/m |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $3K | -57% |
| Q1 2026 | $7K | — |
| Q4 2025 | $7K | — |
| Q3 2025 | $18K | — |
| Q2 2025 | $7K | — |
From Impact Biomedical's 10-Q filed Aug 7, 2026 (on EDGAR).
Questions
How does Impact Biomedical make money?
Impact Biomedical (IBO) made $3K of revenue in the second quarter 2026 (Q2 2026), -57% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.